A mathematical model of the impact of novel treatments on the A burden in the Alzheimer's brain, CSF and plasma
From MaRDI portal
(Redirected from Publication:253301)
A mathematical model of the impact of novel treatments on the A\(\beta\) burden in the Alzheimer's brain, CSF and plasma
A mathematical model of the impact of novel treatments on the A\(\beta\) burden in the Alzheimer's brain, CSF and plasma
Recommendations
- Modeling effect of a \(\gamma \)-secretase inhibitor on amyloid-\(\beta \) dynamics reveals significant role of an amyloid clearance mechanism
- Mathematical model of Alzheimer's disease with prion proteins interactions and treatment
- A mathematical model demonstrating the role of interstitial fluid flow on the clearance and accumulation of amyloid \(\beta\) in the brain
- Exploring the mechanism of \(\beta\)-amyloid toxicity attenuation by multivalent sialic acid polymers through the use of mathematical models
- Analysis of a compartmental model of amyloid beta production, irreversible loss and exchange in humans
Cited in
(11)- A continuous-time mathematical model and discrete approximations for the aggregation of \(\beta \)-amyloid
- The amyloid cascade hypothesis and Alzheimer's disease: a mathematical model
- Alzheimer's disease: analysis of a mathematical model incorporating the role of prions
- Modeling the interaction between \(\beta\)-amyloid aggregates and choline acetyltransferase activity and its relation with cholinergic dysfunction through two-enzyme/two-compartment model
- Modeling the spatial propagation of Aβ oligomers in Alzheimer’s Disease
- Modeling effect of a \(\gamma \)-secretase inhibitor on amyloid-\(\beta \) dynamics reveals significant role of an amyloid clearance mechanism
- Analysis of a compartmental model of amyloid beta production, irreversible loss and exchange in humans
- The synergistic interplay of Amyloid beta and tau proteins in Alzheimer's disease: a compartmental mathematical model
- Stability analysis of a steady state of a model describing Alzheimer's disease and interactions with prion proteins
- Development of \(\mathrm{A}\beta\) and anti-\(\mathrm{A}\beta\) dynamics models for Alzheimer's disease
- Computational causal modeling of the dynamic biomarker cascade in Alzheimer's disease
This page was built for publication: A mathematical model of the impact of novel treatments on the A\(\beta\) burden in the Alzheimer's brain, CSF and plasma
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q253301)
